Additionally, we found that there was no significant difference in SFPQ expression between the MALAT1 high-expressed and low-expressed DLBCL patients or HBV-positive and HBV-negative DLBCL patients (Fig. S10A and S10B). This evidence concerns the gene MALAT1 and diffuse large B-cell lymphoma.